Maynard Um
-
-
-
-
-
-
-
Guggenheim Downgrades Rapt Therapeutics (RAPT) to Neutral
-
-
-
-
-
-
-
GSK receives Japan approval for asthma and nasal polyp treatment
-
-
-
-
-
-
-
GSK terminates collaboration agreement with IDEAYA Biosciences
-
-
-
-
-
-
-
FDA approves GSK's Blenrep for relapsed multiple myeloma treatment
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) Misses Q2 EPS by 71c
-
-
-
-
-
-
-
Bernstein: 'Why Are We Bullish on GlaxoSmithKline (GSK:LN) (GSK) ?'
-
-
-
-
-
-
-
GSK (GSK) to acquire efimosfermin
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

